Aeras
  • About Us
    • About Aeras
    • Leadership
    • Annual Report
    • Funders and Partners
    • Financial Reports
    • Work at Aeras
  • TB Crisis
    • About Tuberculosis
    • The Global Impact
    • The Need For New Vaccines
    • The Case for Investment
  • Portfolio
    • Global Clinical Portfolio
    • Aeras Vaccine Candidates
    • Rational Selection
  • Impact
    • Developing Global Research Capacity
    • Advancing Science
    • Advocacy and Policy
    • Community Engagement
  • Media
    • Aeras in the News
    • Press Releases
    • Scientific Publications
    • Blog
    • Resources
    • Events

Blog

US: Vaccine R&D included in new TB bills

Legislation introduced that would significantly expand funding for tuberculosis.

Posted on June 05, 2007. Categories: Advocacy/Policy News
Read More
‹ First  < 44 45 46

Categories

  • Advocacy/Policy
  • Aeras Africa
  • Aeras Asia
  • Animals
  • Clinical Trials
  • Conferences/Events
  • Diabetes
  • Economics
  • Employee Star Award Winners
  • Healthcare Workers
  • HIV
  • Maternal & Child Health
  • Mining
  • News
  • Research
  • Thaler Lecture Series

Aeras is a nonprofit biotech advancing new TB vaccines for the world

  • About Us
    • About Aeras
    • Leadership
    • Annual Report
    • Funders and Partners
    • Financial Reports
    • Work at Aeras
  • TB Crisis
    • About Tuberculosis
    • The Global Impact
    • The Need For New Vaccines
    • The Case for Investment
  • Media
    • Aeras in the News
    • Press Releases
    • Scientific Publications
    • Blog
    • Resources
    • Events
  • Portfolio
    • Global Clinical Portfolio
    • Aeras Vaccine Candidates
    • Rational Selection
  • Impact
    • Developing Global Research Capacity
    • Advancing Science
    • Advocacy and Policy
    • Community Engagement

Locations

USA

9711 Washingtonian Boulevard
Gaithersburg, MD 20878

P: +1 301 547 2900
F: +1 301 547 2901

South Africa

Blackriver Park, First Floor
Old Warehouse Building
Observatory 7925
Cape Town, South Africa

P: +27 021 442 4980
F: +27 021 447 4806

Contact Us

  • © 2019
  • Privacy Policy
  • Contact